FIELD: medicine. SUBSTANCE: transdermal system consists of integumentary, glue, reservoir and, if necessary, protective layers. Reservoir layer has polymeric material taken from a group of block-copolymer on the basis of styrene and 1,3-diene, polyisobutylene, polymers on the basis of acrylate and/or methacrylate and esters of hydrogenated colophony. The sources of reservoir layer polymeric material: linear block-copolymer styrene-isoprene-styrene, linear block-copolymer styrene-butadiene-styrene, copolymer of 2-ethylhexylacrylate with vinyl acetate, acrylic acid and titanium-chelate-ester, copolymer of 2-ethylhexylacrylate with vinyl acetate and acrylic acid, or copolymer of diethylaminoethylmethacrylate and neutral ester of methacrylic acid. The source of hydrogenated colophony ester: its methyl- or glycerol ester, dioxylcyclohexane, triglyceride or isopropylmyristate, or di-n-butyladipate. Transdermal system releases physostigmine for at least 24 h and retains stability of physostigmine at storage for 3-6 months. EFFECT: increases period of physostigmine releasing, enhanced stability at storage. 2 cl
Title |
Year |
Author |
Number |
TRANSDERMAL THERAPEUTIC SYSTEM AND METHOD FOR PRODUCING THE SYSTEM |
1993 |
- Lotar Dojrer[De]
- Tomas Khille[De]
- Tomas Profitlikh[De]
- Fritts Shtanislaus[De]
- Kersten Val'Ter[De]
|
RU2108812C1 |
ESTRADIOL-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEM |
1994 |
- Rajnkhold Mekoni
- Frank Zajbertts
- Mikhaehl' Khorstmann
- Rajner Likhtenberger
|
RU2140784C1 |
TRANSDERMAL THERAPEUTIC SYSTEM WITH HIGH LEVEL OF USING ACTIVE SUBSTANCE AND DOSE ACCURACY |
2007 |
- Khorstmann Mikhaehl'
- Mjuller Val'Ter
|
RU2454994C2 |
TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL ADMINISTRATION OF GUANFACINE CONTAINING AT LEAST ONE EXCIPIENT |
2018 |
- Emgenbrojkh, Marko
- Prints, Eva-Mari
- Klyajn, Elke
- Klut, Khajke
- Tomas, Ksaver
- Nartker, Linda Syu
|
RU2812734C2 |
TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL INJECTION OF GUANFACINE, CONTAINING SILICONE POLYMER |
2018 |
- Emgenbrojkh, Marko
- Prints, Eva-Mari
- Klyajn, Elke
- Klut, Khajke
- Tomas, Ksaver
- Nartker, Linda Syu
|
RU2792822C2 |
TRANSDERMAL THERAPEUTIC HIGH STABILITY SYSTEMS AND METHOD FOR PRODUCING THEM |
2000 |
|
RU2266735C2 |
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING LAVAND OIL |
2015 |
- Bottsem Petra
- Khille Tomas
|
RU2695785C2 |
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE |
2019 |
- Mor, Patrik
- Ritsher, Rene
- Ejfler, Rene
- Bourkuajn, Olga
|
RU2798017C2 |
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AZENAPINE AND POLYSILOXANE OR POLYISOBUTYLENE |
2017 |
- Mor, Patrik
- Ritsher, Rene
- Ejfler, Rene
- Bourkuajn, Olga
|
RU2764443C2 |
PERCUTANEOUS THERAPEUTIC SYSTEM NOT CONTAINING FIBRE AND METHOD FOR MAKING THEREOF |
2006 |
- Mekoni Rajnkhol'D
- Shuman Klaus
|
RU2386435C2 |